MTOR and Alzheimer disease: However, decreased mTOR activity has been observed in 5xFAD mice, APP/PS1 AD mice, and AD patients, being impaired as a result of exposure to Aβ peptides, contributing to synaptic and cognitive deficiencies [93,94,95].